Blood-camouflaged nanoparticles defeat drug-resistant breast tumors in mouse model in ssalimpour

Salimpour Website |Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant subtypes of breast cancer, accounting for 15% to 20% of all cases. Unlike other breast cancers, TNBC lacks targetable receptors, leaving ...

Phys.Org

Blood-camouflaged nanoparticles defeat drug-resistant breast tumors in mouse model

Blood-camouflaged nanoparticles defeat drug-resistant breast tumors in mouse model

Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant subtypes of breast cancer, accounting for 15% to 20% of all cases. Unlike other breast cancers, TNBC lacks targetable receptors, leaving ...